DK1689349T3 - Fremgangsmåde til induktion af melanogenese i mennesker med variante MC1R-alleler - Google Patents

Fremgangsmåde til induktion af melanogenese i mennesker med variante MC1R-alleler

Info

Publication number
DK1689349T3
DK1689349T3 DK04797078.5T DK04797078T DK1689349T3 DK 1689349 T3 DK1689349 T3 DK 1689349T3 DK 04797078 T DK04797078 T DK 04797078T DK 1689349 T3 DK1689349 T3 DK 1689349T3
Authority
DK
Denmark
Prior art keywords
mc1r
alleles
humans
variant
inducing melanogenesis
Prior art date
Application number
DK04797078.5T
Other languages
English (en)
Inventor
Stuart Michael Humphrey
Original Assignee
Clinuvel Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003906813A external-priority patent/AU2003906813A0/en
Application filed by Clinuvel Pharmaceuticals Ltd filed Critical Clinuvel Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK1689349T3 publication Critical patent/DK1689349T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK04797078.5T 2003-11-24 2004-11-23 Fremgangsmåde til induktion af melanogenese i mennesker med variante MC1R-alleler DK1689349T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003906813A AU2003906813A0 (en) 2003-11-24 Method of Inducing Melanogenesis in Humans
PCT/AU2004/001630 WO2005048967A1 (en) 2003-11-24 2004-11-23 A method of inducing melanogenesis in humans with mc1r variant alleles

Publications (1)

Publication Number Publication Date
DK1689349T3 true DK1689349T3 (da) 2013-12-02

Family

ID=34596446

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04797078.5T DK1689349T3 (da) 2003-11-24 2004-11-23 Fremgangsmåde til induktion af melanogenese i mennesker med variante MC1R-alleler

Country Status (8)

Country Link
US (1) US7745408B2 (da)
EP (1) EP1689349B9 (da)
JP (1) JP5230941B2 (da)
CA (1) CA2547083C (da)
DK (1) DK1689349T3 (da)
NZ (1) NZ547383A (da)
WO (1) WO2005048967A1 (da)
ZA (1) ZA200605153B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1689349T3 (da) 2003-11-24 2013-12-02 Clinuvel Pharmaceuticals Ltd Fremgangsmåde til induktion af melanogenese i mennesker med variante MC1R-alleler
CA2582607C (en) * 2004-10-08 2016-07-12 Clinuvel Pharmaceuticals Limited Compositions and methods for inducing melanogenesis in a subject
WO2008025074A1 (en) * 2006-08-28 2008-03-06 Clinuvel Pharmaceuticals Limited Method for reducing incidence or rate of development of skin cancers and related conditions
US8603435B2 (en) 2008-01-10 2013-12-10 Stc.Unm Compounds and methods for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
CA2716509A1 (en) * 2008-02-22 2009-08-27 Clinuvel Pharmaceuticals Limited Method for treatment of photosensitivity and phototoxicity
KR101687037B1 (ko) 2008-06-09 2016-12-15 팔라틴 테크놀로지스 인코포레이티드 성기능 장애 치료용 멜라노코르틴 수용체-특이적 펩티드
EP2440572B1 (en) 2009-06-08 2017-04-05 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
CA2761607C (en) 2009-06-08 2018-09-04 Yi-Qun Shi Melanocortin receptor-specific peptides
BR112012011780A2 (pt) 2009-11-23 2019-09-24 Palatin Technologies, Inc peptídeo linear,composição farmacêutica,métodopara tratamento de umadoença,indicação,condição ou sídrome mediadsa por receptor de melanocortina emum mamífero humano ou não humano e método para tratamento de uma condição responsiva ás alterações em função de receptor de melanocortina em um mamifero humano ou não humano
JP5999702B2 (ja) 2009-11-23 2016-09-28 パラティン テクノロジーズ, インコーポレイテッドPalatin Technologies, Inc. メラノコルチン−１受容体特異的環状ペプチド
CA2892144C (en) 2012-11-21 2020-04-28 University Of Cincinnati Pharmaceutical compositions and therapeutic methods of use comprising selective agonists of melanocortin 1 receptor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457864A (en) * 1981-10-23 1984-07-03 University Patents, Inc. Synthetic analogues of α-melanotropin
US4485039A (en) * 1982-06-11 1984-11-27 University Patents, Inc. Synthetic analogues of α-melanotropin
ATE84420T1 (de) * 1986-02-03 1993-01-15 University Patents Inc Verfahren zur stimulierung von melanozyten durch lokales anbringen von alpha-msh-analogen, sowie zusammensetzungen.
US5674839A (en) * 1987-05-22 1997-10-07 Competitive Technologies, Inc. Cyclic analogs of alpha-MSH fragments
US5683981A (en) * 1987-05-22 1997-11-04 Competitive Technologies, Inc. Cyclic bridged analogs of α-MSH and methods thereof
US5049547A (en) * 1988-02-11 1991-09-17 University Patents, Inc. Composition for stimulating integumental melanocytes
AU2003206496B2 (en) 2002-02-26 2007-08-02 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method of stimulation of melanin production and induction of skin tanning
DK1689349T3 (da) 2003-11-24 2013-12-02 Clinuvel Pharmaceuticals Ltd Fremgangsmåde til induktion af melanogenese i mennesker med variante MC1R-alleler

Also Published As

Publication number Publication date
CA2547083A1 (en) 2005-06-02
US7745408B2 (en) 2010-06-29
WO2005048967A1 (en) 2005-06-02
NZ547383A (en) 2009-11-27
EP1689349B9 (en) 2014-02-26
EP1689349B1 (en) 2013-09-18
ZA200605153B (en) 2008-04-30
EP1689349A1 (en) 2006-08-16
JP5230941B2 (ja) 2013-07-10
JP2007514656A (ja) 2007-06-07
EP1689349A4 (en) 2008-11-26
US20080004213A1 (en) 2008-01-03
CA2547083C (en) 2019-05-14

Similar Documents

Publication Publication Date Title
EP1738417A4 (en) PHOTOVOLTAIC SYSTEM AND METHODS OF MANUFACTURING THE SAME
DK2308507T3 (da) Fremgangsmåder til behandling af præeklampsi
ATA17052002A (de) Bauteil zur wärmeableitung
DE602005001933D1 (de) Kühlsystem
DK1997512T3 (da) Fremgangsmåder til behandling af TWEAK-relaterede tilstande
DK1784079T3 (da) Fremgangsmåde til reduktion af acrylamid-dannelse i termisk forarbejdede fødevarer
DE602004005096D1 (de) Kamera und Kontrollverfahren dafür
DE602005001520D1 (de) Zeiteinstellungssystem und Zeiteinstellungsverfahren
DE602005013968D1 (de) Polyorganosiloxan und härtbare zusammensetzung daraus
DK1689349T3 (da) Fremgangsmåde til induktion af melanogenese i mennesker med variante MC1R-alleler
DK1626736T3 (da) C1-inhibitor med kort halveringstid til midlertidig behandling
EP1599904A4 (en) STRUCTURE AND METHOD FOR LATERAL LUBISTOR
FR2855771B1 (fr) Thermocycleur
DE602005026425D1 (de) Stranggussvorrichtung und -verfahren
DE602005007446D1 (de) Relais-Vorrichtung und Relais-Methode
DE602005002680D1 (de) Härtbare Organopolysiloxanzusammensetzung
FI20021531A0 (fi) Muurausmenetelmä
DE60327836D1 (de) PVD-Vorrichtung und Verfahren
NO20035401D0 (no) Metode
FI20045252L (fi) AV-järjestelmä sekä ohjain
DE602004012264D1 (de) Verbesserungen bei thermischer reglern
ITTO20030447A1 (it) Metodo di rappresentazione in sicurezza mediante
SE0502219L (sv) Kylsystem med förrengöring
LU91202B1 (de) Palisadensystem
FR2860392B1 (fr) Petrin manuel